ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.4285
0.00%
Brent Oil
74.65
0.00%
Bitcoin
96,163.64
-1.66%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Pivotal Therapeutics Inc (CE) (PVTTF) Cotización

Pivotal Therapeutics Inc (CE)

Pivotal Therapeutics Inc (CE) (PVTTF)

USOTC
0.0018
0.00
(0.00%)
Cerrado 24 Noviembre 3:00PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.0018
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.0018 Rango de 52 semanas 0.0018
Precio Anterior
0.0018
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

PVTTF Últimas noticias

Más noticias

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100 PR Newswire WOODBRIDGE, ON, June 4, 2015 WOODBRIDGE, ON, June 4, 2015 /PRNewswire/ - Pivotal Therapeutics Inc...

04 Junio 2015
PR Newswire (US)

Pivotal Therapeutics Announces First Quarter Financial Results

Pivotal Therapeutics Announces First Quarter Financial Results PR Newswire WOODBRIDGE, ON, June 1, 2015 WOODBRIDGE, ON, June 1, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE:...

01 Junio 2015
PR Newswire (US)

Pivotal Therapeutics Inc. is to be Featured on CEO Clips on CBC's The Documentary Channel

Pivotal Therapeutics Inc. is to be Featured on CEO Clips on CBC's The Documentary Channel PR Newswire WOODBRIDGE, May 11, 2015 WOODBRIDGE, May 11, 2015 /PRNewswire/ - Pivotal Therapeutics...

11 Mayo 2015
PR Newswire (US)

Pivotal Therapeutics Announces 2014 Financial Results

Pivotal Therapeutics Announces 2014 Financial Results PR Newswire WOODBRIDGE, ON, April 30, 2015 WOODBRIDGE, ON, April 30, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO...

30 Abril 2015
PR Newswire (US)

Pivotal receives Health Canada approval to expand the indication of OMAZEN® to include products with claims to maintain and ...

Pivotal receives Health Canada approval to expand the indication of OMAZEN® to include products with claims to maintain and support cardiovascular health and normal triglyceride levels PR...

27 Abril 2015
PR Newswire (US)

Pivotal executes Memorandum of Understanding for exclusive distribution of Benefishial™ line of products in Korea

Pivotal executes Memorandum of Understanding for exclusive distribution of Benefishial™ line of products in Korea PR Newswire WOODBRIDGE, ON, April 15, 2015 WOODBRIDGE, ON, April 15, 2015...

15 Abril 2015
PR Newswire (US)

Pivotal Therapeutics and French University Hospital of Strasbourg Announce POMEGA Trial Chief Investigator Dr. Yannick Georg ...

Pivotal Therapeutics and French University Hospital of Strasbourg Announce POMEGA Trial Chief Investigator Dr. Yannick Georg Laureate of EUR 30,000 French Interregional Clinical Research and...

07 Abril 2015
PR Newswire (US)

Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients T...

Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients That Includes VASCAZEN® and an Omega-3 Fatty Acid Diagnostic Assay PR...

01 Abril 2015
PR Newswire (US)

Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients T...

Pivotal Receives Notice of Allowance For U.S. Patent Related to a Kit for the Dietary Management of Cardiovascular Patients That Includes VASCAZEN® and an Omega-3 Fatty Acid Diagnostic...

01 Abril 2015
PR Newswire (US)

Pivotal Therapeutics announces payment of interest on outstanding convertible notes

Pivotal Therapeutics announces payment of interest on outstanding convertible notes PR Newswire WOODBRIDGE, ON, March 26, 2015 WOODBRIDGE, ON, March 26, 2015 /PRNewswire/ - Pivotal Therapeutics...

26 Marzo 2015
PR Newswire (US)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
12000.00180.00180.001800CS
26000.00180.00180.001800CS
52000.00180.00180.001800CS
156-0.0382-95.50.040.041.0E-6294640.00029344CS
260-0.0032-640.0050.161.0E-6298910.02496563CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0.0238
(2,379,900.00%)
13.46k
CNVIFConavi Medical Corporation (PK)
US$ 0.58
(82,757.14%)
2.25k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.00055
(54,900.00%)
342.7k
RQHTFReliq Health Technologies Inc (CE)
US$ 0.0003
(29,900.00%)
219.11k
ELOXEloxx Pharmaceuticals Inc (CE)
US$ 0.0001
(9,900.00%)
1.53k
FDVXFFenixOro Gold Corporation (CE)
US$ 0.000001
(-100.00%)
10k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.000001
(-99.98%)
200
HLLPFHello Pal International Inc (CE)
US$ 0.000001
(-99.90%)
6k
MOTSMotus GI Holdings Inc (CE)
US$ 0.000001
(-99.88%)
649
BTAEFBeta Energy Corporation (CE)
US$ 0.000001
(-99.67%)
655
RSHNRushNet Inc (PK)
US$ 0.00015
(-25.00%)
502.31M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
428.38M
ASTAAstra Veda Corporation (PK)
US$ 0.0002
(-33.33%)
364.38M
RDARRaadr Inc (PK)
US$ 0.0009
(50.00%)
276.07M
CGACCode Green Apparel Corp (PK)
US$ 0.00065
(44.44%)
225.16M

PVTTF Discussion

Ver más
makinezmoney makinezmoney 6 años hace
$PVTTF: $0.004 now.... chance to go to $0.02

Very thin float.


GO $PVTTF
👍️0
makinezmoney makinezmoney 7 años hace
$PVTTF: Ready to roll now....... should be jumping

$0.006 is next.

Make it HAPPEN :)


Lets go $PVTTF......... Super UNDERVALUED !!!!!!!!!!!



👍️0
makinezmoney makinezmoney 7 años hace
$PVTTF: Now touching $0.0039

Slowly some volume starting to roll in.

There is a very very thin float to the upside here.


Great setup here.



GO $PVTTF
👍️0
makinezmoney makinezmoney 7 años hace
$PVTTF: I'm watching you here $PVTTF... now $0.0021

You're a Low Floater and you were at $0.11 just
3yrs ago.


I like you right now and saw some volume coming in past few days.

Whats going on ?








$PVTTF
👍️0
chaostrader chaostrader 10 años hace
it needs life
👍️0
detuna detuna 10 años hace
also trades Canada symbol pvo
👍️0
ListenToMe ListenToMe 10 años hace
2 followers
👍️0
BingBing90 BingBing90 11 años hace
Do you still own this ?
👍️0
chaostrader chaostrader 11 años hace
Yup, imma buyer!
👍️0

Su Consulta Reciente

USOTC
PVTTF
Pivotal Therapeutics (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados